201109-eli-lilly-antibody-jm-1904_c94e475b60cee94d90244fc20a0cc0a5.jpg

  • November 9, 2020
  • 0
  • 3 Views

FILE – In this May 2020 photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis. The drug company says it has asked the U.S. government to allow emergency use of an experimental antibody therapy based on early results from a study suggesting the drug reduced symptoms, the amount of virus and hospitalizations and ER visits for patients with mild or moderate COVID-19. Eli Lilly and Company announced the partial results Wednesday, Oct. 7 in a news release; they have not yet been published or reviewed by independent scientists. Its drug is similar to one that President Donald Trump received on Friday, Oct. 2 from Regeneron Pharmaceuticals Inc. (David Morrison/Eli Lilly via AP, File)


Upstate News Headlines

PHP Code Snippets Powered By : XYZScripts.com